Filing Details
- Accession Number:
- 0001735276-20-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 16:08:43
- Reporting Period:
- 2020-02-07
- Accepted Time:
- 2020-02-11 16:08:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1458494 | Akshay Vaishnaw | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-07 | 18,750 | $42.22 | 30,923 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-07 | 4,000 | $42.22 | 34,923 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-07 | 23,708 | $125.00 | 11,215 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Stock Option 2016 (right to buy) | Disposition | 2020-02-07 | 4,000 | $0.00 | 4,000 | $42.22 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-02-07 | 18,750 | $0.00 | 18,750 | $42.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,000 | 2019-08-06 | 2026-12-20 | No | 4 | M | Direct |
| 6,250 | 2026-12-20 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 515 | Indirect | by Managed Account |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 04, 2019.
- Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Billionaire Hedge Funds
